The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 12, 2010, Pages 2298-2306

  Jentzen, Walter ^a   Balschuweit, Dorothee ^b   Schmitz, Jochen ^a   Freudenberg, Lutz ^a   Eising, Ernst ^a   Hilbel, Thomas ^b   Bockisch, Andreas ^a   Stahl, Alexander ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Fachbereich Physikalische Technik   (Germany)

Author keywords

Dosimetry; Iodine 124; Radioiodine therapy; Salivary gland; Thyroid cancer

Indexed keywords

IODINE 124; IODINE 131;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEMON JUICE; MALE; PAROTID GLAND; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; SALIVARY GLAND; SALIVATION; STIMULATION; SUBMANDIBULAR GLAND; THYROID CANCER;

ADULT; AGED; CITRUS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PLANT EXTRACTS; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; SALIVA; SALIVARY GLANDS; SALIVATION; SIALOGRAPHY; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649780370     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1532-z     Document Type: Article

References (12)

1. S Hyer A Kong B Pratt C Harmer 2007 Salivary gland toxicity after radioiodine therapy for thyroid cancer Clin Oncol 19 83 86 1:STN:280: DC%2BD2s7gsFKgtw%3D%3D 10.1016/j.clon.2006.11.005 (Pubitemid 46044071)
2. M Luster SE Clarke M Dietlein M Lassmann P Lind WJ Oyen, et al. 2008 Guidelines for radioiodine therapy of differentiated thyroid cancer Eur J Nucl Med Mol Imaging 35 1941 1959 1:STN:280:DC%2BD1cnhvVaqtQ%3D%3D 10.1007/s00259-008-0883-1 18670773
3. SJ Mandel L Mandel 2003 Radioactive iodine and the salivary glands Thyroid 13 265 271 1:CAS:528:DC%2BD3sXjtVymtLc%3D 10.1089/105072503321582060 12729475
4. H Creutzig 1985 Sialadenitis following iodine-131 therapy for thyroid carcinoma: Letter to the editor J Nucl Med 26 817
5. P Allweiss GD Braunstein A Katz A Waxman 1985 Re: Sialadenitis following I-131 therapy for thyroid carcinoma: Letter to the editor J Nucl Med 26 817
6. D Van Nostrand F Atkins VV Bandaru SP Chennupati S Moreau K Burman, et al. 2009 Salivary gland protection with sialagogues: a case study Thyroid 19 1005 1008 10.1089/thy.2008.0381 19500022
7. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer DS Cooper GM Doherty BR Haugen RT Kloos SL Lee SJ Mandel, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167 1214 10.1089/thy.2009.0110 19860577
8. K Nakada T Ishibashi T Takei K Hirata K Shinohara S Katoh, et al. 2005 Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46 261 266 15695785
9. 124I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer Eur J Nucl Med Mol Imaging 37 884 895 1:CAS:528:DC%2BC3cXkslakt7Y%3D 10.1007/s00259-009-1351-2 20069293
10. 124I-PET/CT in staging of patients with differentiated thyroid cancer Eur Radiol 14 2092 2098 1:STN:280:DC%2BD2crjtVGmtw%3D%3D 10.1007/s00330-004-2350-0 15232708 (Pubitemid 39481183)
11. W Jentzen R Weise J Kupterschlager I Freudenberg W Brandau R Bares, et al. 2008 Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems Eur J Nucl Med Mol Imaging 35 611 623 10.1007/s00259-007-0554-7 17929014 (Pubitemid 351661669)
12. W Jentzen 2010 Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging Phys Med Biol 55 2365 2398 10.1088/0031-9155/55/8/016 20360631